Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Pulmonary Hypertension

  Free Subscription


23.02.2026

1 Adv Respir Med
1 Adv Ther
1 Am J Physiol Heart Circ Physiol
1 Arch Biochem Biophys
1 Cardiol Rev
1 Cardiovasc Toxicol
1 Circ Cardiovasc Imaging
1 Clin Exp Hypertens
1 Cureus
1 Curr Probl Cardiol
1 ERJ Open Res
2 ESC Heart Fail
1 Eur Heart J Case Rep
2 Eur Respir J
1 Eur Respir Rev
1 Front Cardiovasc Med
1 Front Immunol
1 Front Med (Lausanne)
1 Front Vet Sci
1 J Am Heart Assoc
1 J Cardiothorac Surg
3 J Perinatol
1 Pediatr Pulmonol
3 Pediatr Res
2 Pulm Circ
1 Reports (MDPI)
1 Respir Investig


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Respir Med

  1. ALRASHEDI S, Alharbi L, Alotaibi M, Alzahrani I, et al
    Evaluating the Impact of Inspiratory Muscle Training on Respiratory Function and Exercise Capacity in Pulmonary Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Adv Respir Med. 2026;94:13.
    PubMed         Abstract available


    Adv Ther

  2. HABIB NG, Adhia A, Lopez D, Sandros M, et al
    Selection of Endothelin Receptor Antagonists in the Treatment of Pulmonary Arterial Hypertension: A Comprehensive Narrative Review.
    Adv Ther. 2026;43:468-519.
    PubMed         Abstract available


    Am J Physiol Heart Circ Physiol

  3. OAKLAND HT, Bellumkonda L, Sugeng L, Joseph P, et al
    3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension.
    Am J Physiol Heart Circ Physiol. 2026;330:H729-H736.
    PubMed         Abstract available


    Arch Biochem Biophys

  4. QI Y, Dong Q, Luo P, Meng J, et al
    USP15 promotes proliferation, migration, and apoptosis resistance of pulmonary arterial smooth muscle cells by targeting MDM2.
    Arch Biochem Biophys. 2026;778:110733.
    PubMed         Abstract available


    Cardiol Rev

  5. ALOWAMI M, Ch'ng BX, Babasola RO, Tan CH, et al
    Efficacy and Safety of Selexipag in Pulmonary Hypertension: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Cardiol Rev. 2026 Feb 18. doi: 10.1097/CRD.0000000000001185.
    PubMed         Abstract available


    Cardiovasc Toxicol

  6. CHENG K, Zheng T, Guo L, Guo M, et al
    GLI1 Promotes Hypoxia Induced Pyroptosis of PASMCs and Aggravates Pulmonary Arterial Hypertension in Rats by Upregulating HDAC1 Expression.
    Cardiovasc Toxicol. 2026;26:28.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  7. MILES KG, Dorobantu DM, Douwes JM, Frank BS, et al
    Current State of RV Multimodality Imaging in Pediatric Pulmonary Hypertension: Current Evidence, Knowledge Gaps, and Future Research Directions.
    Circ Cardiovasc Imaging. 2026 Feb 19:e019264.
    PubMed         Abstract available


    Clin Exp Hypertens

  8. LI H, Li M, Qiu C, Yang Y, et al
    Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation.
    Clin Exp Hypertens. 2026;48:2629926.
    PubMed         Abstract available


    Cureus

  9. KUME H, Nosaka N, Yasumura R
    Venoarterial Extracorporeal Membrane Oxygenation Rescue for Catastrophic Grade 3 Bone Cement Implantation Syndrome in a Patient With Aortic Valve Stenosis and Moderate Pulmonary Hypertension: A Case Report.
    Cureus. 2026;18:e101514.
    PubMed         Abstract available


    Curr Probl Cardiol

  10. MANCA P, Puglisi S, Pascalis L, Nuzzi V, et al
    Prognostic Role of Invasively Determined Pulmonary Hypertension in Ambulatory Patients with Advanced Heart Failure: A Prospective Cohort Study.
    Curr Probl Cardiol. 2026 Feb 14:103301. doi: 10.1016/j.cpcardiol.2026.103301.
    PubMed         Abstract available


    ERJ Open Res

  11. RIOU M, Beurnier A, Montani D
    Pulmonary hypertension associated with COPD: exploring the complex spectrum of an unmet clinical challenge.
    ERJ Open Res. 2026;12:01153-2025.
    PubMed         Abstract available


    ESC Heart Fail

  12. SCELSI L, Badagliacca R, D'Alto M, Acquaro M, et al
    Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up.
    ESC Heart Fail. 2026;13:xvaf012.
    PubMed         Abstract available

  13. MELIN M, Lofman IH, Matan D, Nygren M, et al
    Agreement of thermodilution and direct Fick methods for cardiac output across varying haemodynamic conditions.
    ESC Heart Fail. 2026;13:xvaf001.
    PubMed         Abstract available


    Eur Heart J Case Rep

  14. PHU QUY H, Doan Duc D, Nguyen Duc T
    A diagnostic challenge: unveiling chronic thromboembolic pulmonary hypertension in the absence of visible thrombi: a case report.
    Eur Heart J Case Rep. 2026;10:ytag034.
    PubMed         Abstract available


    Eur Respir J

  15. JUTANT EM, Grynblat J, Pyrrait M, Lechartier B, et al
    Pulmonary hypertension associated with hereditary hemorrhagic telangiectasia: from genetics to clinical management.
    Eur Respir J. 2026 Feb 19:2502322. doi: 10.1183/13993003.02322-2025.
    PubMed         Abstract available

  16. REDDY YNV, Frantz RP, Miranda WR, Varma R, et al
    Pathophysiology and prevalence of high output heart failure in group 1 pulmonary hypertension.
    Eur Respir J. 2026 Feb 19:2501871. doi: 10.1183/13993003.01871-2025.
    PubMed         Abstract available


    Eur Respir Rev

  17. VILLA A, Sanges S, Sobanski V, Lamblin N, et al
    Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.
    Eur Respir Rev. 2026;35:250137.
    PubMed         Abstract available


    Front Cardiovasc Med

  18. BHADRA OD, Weimann J, Waldschmidt L, Demal TJ, et al
    Long-term outcome of patients with severe pulmonary hypertension undergoing transcatheter aortic valve implantation.
    Front Cardiovasc Med. 2026;12:1678025.
    PubMed         Abstract available


    Front Immunol

  19. MOHAMED-ALI N, Acquaah V, Al-Jaber M, Bhatt R, et al
    Systemic sclerosis-associated pulmonary arterial hypertension and pulmonary fibrosis: exploring biomarker discriminators with advanced omics in a Caucasian cohort.
    Front Immunol. 2026;17:1755076.
    PubMed         Abstract available


    Front Med (Lausanne)

  20. QUE W, Li S, Li J, Li Y, et al
    The effect of atorvastatin combined with azithromycin on lung function and right heart function in COPD patients with concomitant pulmonary hypertension.
    Front Med (Lausanne). 2026;12:1667773.
    PubMed         Abstract available


    Front Vet Sci

  21. NICOL C, Kristrom K, Bettembourg V
    Case Report: Anaesthetic management in a canine patient with severe atrioventricular septal defect and pulmonary hypertension undergoing non-cardiac surgery.
    Front Vet Sci. 2026;13:1736215.
    PubMed         Abstract available


    J Am Heart Assoc

  22. SIUBA MT, Lane J, Mendpara V, Toth D, et al
    Cardiac Output During Exercise: Thermodilution Versus Direct Fick.
    J Am Heart Assoc. 2026;15:e047657.
    PubMed         Abstract available


    J Cardiothorac Surg

  23. WANG B, Zhang Z, Chen K, Qin Y, et al
    Fatal pulmonary artery dissection in the setting of aneurysm and pulmonary hypertension: a case report and literature review.
    J Cardiothorac Surg. 2026 Feb 16. doi: 10.1186/s13019-026-03880.
    PubMed        


    J Perinatol

  24. RAMACHANDRA R, Arunamata A, Moy A, Tracy MC, et al
    Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia.
    J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02580.
    PubMed         Abstract available

  25. FOOTE HP, Sun M, Goldstein BA, Hill KD, et al
    Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia.
    J Perinatol. 2026 Feb 16. doi: 10.1038/s41372-026-02576.
    PubMed         Abstract available

  26. MORRIS H, Reilly M, Zhang H, Dong X, et al
    Characteristics associated with death or tracheostomy in infants with bronchopulmonary dysplasia following predominant non-invasive respiratory support.
    J Perinatol. 2025 Feb 22. doi: 10.1038/s41372-025-02234.
    PubMed         Abstract available


    Pediatr Pulmonol

  27. TSANG KD, Caudri D, Zaat C, Tramper-Stranders GA, et al
    Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia.
    Pediatr Pulmonol. 2026;61:e71517.
    PubMed         Abstract available


    Pediatr Res

  28. JENKINSON A, Harris C, Bafadhel M, Razavi R, et al
    Longitudinal changes in cardiopulmonary outcomes of adults born extremely prematurely: United Kingdom Oscillation Study.
    Pediatr Res. 2025 Jun 16. doi: 10.1038/s41390-025-04190.
    PubMed         Abstract available

  29. CHEN Q, Lin L, Xiong S, Ge D, et al
    Risk factors for severe pertussis in children and the application of exchange transfusion.
    Pediatr Res. 2026;99:248-253.
    PubMed         Abstract available

  30. NOH CY, Danzer E, Bhombal S, Chock VY, et al
    Early postnatal echocardiographic characteristics impact survival and extracorporeal life support in congenital diaphragmatic hernia.
    Pediatr Res. 2025 Oct 1. doi: 10.1038/s41390-025-04443.
    PubMed         Abstract available


    Pulm Circ

  31. GUPFERT M, Weber L, Haager PK, Baier P, et al
    Impact of Right Heart Catheterization and the 2022 ESC/ERS Definition of Pulmonary Hypertension in Patients With Mitral Regurgitation Undergoing Valve Repair/Replacement.
    Pulm Circ. 2026;16:e70265.
    PubMed         Abstract available

  32. HOWARD LS, Kiely DG, Lawrie A, Maron BA, et al
    Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study.
    Pulm Circ. 2026;16:e70258.
    PubMed         Abstract available


    Reports (MDPI)

  33. PASQUINUCCI M, Bonsembiante L, Mezzalira S, Locallo M, et al
    A Rare Case of Reversible Pulmonary Hypertension Phenotype in a Child with Scurvy: Aetiologies Insights.
    Reports (MDPI). 2026;9:44.
    PubMed         Abstract available


    Respir Investig

  34. YAMAMOTO S, Sakamaki F
    Current perspectives on imaging modalities in the diagnosis and management of pulmonary hypertension.
    Respir Investig. 2026;64:101389.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum